We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.47%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$5.64M
(+5.4%)
Cap. Flow
-$3.19M
Cap. Flow
% of AUM
-2.88%
Top 10 Holdings %
Top 10 Hldgs %
22.16%
Holding
62
New
–
Increased
3
Reduced
57
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$643K |
| 2 |
Target
TGT
|
+$234K |
| 3 |
Kroger
KR
|
+$137K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$400K |
| 2 |
Microsoft
MSFT
|
+$164K |
| 3 |
Broadcom
AVGO
|
+$92.8K |
| 4 |
Old Republic International
ORI
|
+$92.6K |
| 5 |
General Dynamics
GD
|
+$87.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.16% |
| 2 | Healthcare | 13.3% |
| 3 | Industrials | 11.84% |
| 4 | Technology | 9.38% |
| 5 | Energy | 8.99% |
Similar funds
EW
ANBOT
P
SPW
SHF
NS
ACA
HA
Weaver C. Barksdale & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Weaver C. Barksdale & Associates held 62 positions worth $111M, up 5.4% from $105M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 0%. Weaver C. Barksdale & Associates opened no new positions and made no exits, leaving the 62-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
- Weaver C. Barksdale & Associates added most to J.M. Smucker in Q3 2024, an estimated $643K increase.
- Weaver C. Barksdale & Associates's biggest Q3 2024 reduction was Aflac, cutting an estimated $400K.
- Weaver C. Barksdale & Associates's ten largest holdings make up 22% of its $111M portfolio in Q3 2024.
- Weaver C. Barksdale & Associates opened 0 new positions and closed 0 in Q3 2024.
- Weaver C. Barksdale & Associates's portfolio value rose 5.4% quarter-over-quarter to $111M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.